Article
Chronic kidney disease onset, progression, and cardiovascular outcomes: proteomics informs biology and risk stratification.
Cardiovascular diabetology - 20 Jan 2026
Zhang Jijuan, Yu Hancheng, Song Xingyue, Li Xianli, Xie Jinchi, Wang Yuxiang, Li Yue, Xu Kun, Liu Gang, Liao Yunfei, Ruan Xiong-Zhong, Pan An, Geng Tingting
Abstract excerpt
BACKGROUND: Large-scale proteomics provides an opportunity to understand chronic kidney disease (CKD) and cardiovascular disease, yet research in this field is limited. This study utilized proteomics to inform biology and risk stratification for these diseases. METHODS: This cohort study included 44,779 participants free of prevalent CKD, and 3,749-4,272 participants with prevalent CKD from the UK Biobank. The...
Topics
- Humans
- Proteomics
- Risk Assessment
- Renal Insufficiency, Chronic
- Disease Progression
- UK Biobank
- Female
- Middle Aged
- Biomarkers
- Male
- Prognosis
